Drugs / brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination
brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00822081 Comparator | Jan 2005 → Apr 2006 | ocular hypertension, open-angle glaucoma | Bp Consulting, Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00822081 ↗ |
| Route | Topical | “received topical brimonidine-timolol BID or dorzolamide-timolol BID” PMID 19476406 ↗ Jul 2009 |